A preventive measure for otitis media in children with upper respiratory tract infections

International Journal of Pediatric Otorhinolaryngology

Volumn 63, Issue 2, 2002, Pages 111-118

  Mora, R ^a,b   Barbieri, M ^a   Passali, G C ^a   Sovatzis, A ^a   Mora, F ^a   Cordone, M P ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b Largo Rosanna Benzi   (Italy)

Author keywords

OME; Otitis media; Ribosomal immunotherapy; Upper respiratory tract infections (URTI)

Indexed keywords

RIBOMUNYL;

ADOLESCENT; ARTICLE; CLINICAL ARTICLE; CONSULTATION; CONTROLLED STUDY; FEMALE; HEARING; HUMAN; IMMUNOTHERAPY; INCIDENCE; MALE; OTITIS MEDIA; PRESCHOOL CHILD; PRIORITY JOURNAL; RECIPIENT; RECURRENT INFECTION; SCHOOL CHILD; TABLET; UPPER RESPIRATORY TRACT INFECTION;

ADMINISTRATION, ORAL; ADOLESCENT; ANTIGENS, BACTERIAL; CHILD; CHILD, PRESCHOOL; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; OTITIS MEDIA; PROBABILITY; RECURRENCE; REFERENCE VALUES; RESPIRATORY TRACT INFECTIONS; RISK ASSESSMENT; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 0037171658     PISSN: 01655876     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5876(01)00649-8     Document Type: Article

References (42)

1. Infections of the ear, nose and throat
2. Sinusitis
3. Recurrent respiratory tract infections in paediatric patients
4. Practice patterns versus practice guidelines in paediatric otitis media
5. Economic evaluation of ribosomal immunotherapy in patients with chronic ear, nose and throat and respiratory tract infections: results for Italy
6. Prevalence and relationship between allergic diseases and infectious diseases
7. Cost effectiveness of immunoprophylaxis in the prevention of recurrent infectious rhinitis in adults
8. Epidemiology of documented viral respiratory infections and acute otitis media in a cohort of children followed from two to twenty-four months of age
9. Recurrent respiratory infections in childhood: experience with a bacterial extract plus bacterial ribosomes (Immucytol®)
10. Immunoglobulin production in man stimulated by orally administered bacterial lysate (Broncho-Vaxom)
11. Prevention of bacterial respiratory infections using a ribosomal vaccine [in French]
12. Oral administration of streptococcal antigen coupled to cholera toxin B subunit evokes strong antibody responses in salivary glands and extramucosal tissues
13. Biological activity of bacterial cell wall components: immunogenicity of an immunostimulating bacterial extract
14. The mucosal immune system. From fundamental concepts-to vaccine development
15. Cytokine and Ig-producing cells in mucosal effector tissues analysis of IL-5 and IFN-y producing cells, T cells, T cell receptor expression and IGA plasma cells from mouse salivary gland-associated tissues
16. Overview of the mucosal immune system
17. Stimulation of NK cells using Klebsiella Pneumoniae membrane proteoglycans
18. Stimulation of cytotoxic and non-cytotoxic functions of natural killer cells by bacterial membrane proteoglycans and ribosomes
19. Chemotactic cytokine gene expression and production induced in human monocytes by membrane proteoglycans from Klebsiella Pneumoniae
20. Bacterial ribosomal immunostimulants prime alveolar macrophages in vivo to produce interleukin 1 in vitro
21. Effect of an in vivo immunostimulant treatment on PMN functions: interaction with antibiotics in vitro
22. Immunostimulant effects on granulocyte functions during an acute respiratory infection
23. Antibody-producing cells in peripheral blood and tonsils after oral treatment of children with bacterial ribosomes
24. Immucytal in the prevention and treatment of recurrent upper respiratory tract infections in children: a randomised, placebocontrolled, double-blind study
25. Efficacy of Ribomunyl in the prevention of recurrent upper respiratory tractinfections [in French]
26. Clinical experience with Biomunil tablets in children with recurrent respiratory infections
27. Prophylaxis of recurrent respiratory infections in children with a new immunomodulating agent
28. Prevention of recurrent ear, nose and throat infections with Ribomunyl tablets in children aged less than 5 years [in French]
29. Prevention of recurrent ear, nose and throat infections in young children with Ribomunyl: double-blind, placebo-controlled study
30. Effectiveness of ribosomal fractions of Klebsiella pneumoniae, Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae and the membrane fracfion of Kp (Riboomunyl) in the prevention of clinical recurrences of infectious rhinitis: results of a multicenter double-blind placebo-controlled study
31. Relapsing tonsillitis: prevention with a ribosomal vaccine
32. Place of different forms of Ribomunyl in the treatment of recurrent respiratory tract infections [in French]
33. Bacterial etiology of otitis media with effusion in a group of Lebanese children